Industry Developments

BMI View: The Turkish pharmaceutical industry's hostility towards the government's pricing policy is clear and continues to reinforce BMI's own view on the endemic challenges in this... 2011-05-18

BMI View: Our view that Latvia will return only weak pharmaceutical market growth in 2011 remains firmly in play. The performance of this market remains indelibly tied to the country's... 2011-05-17

BMI View: The rapid development of Ukraine's pharmaceutical market has attracted strong interest from multinational drugmakers as a lucrative import destination and we hold our view... 2011-05-17

BMI View: Despite its exposure to high-growth pharmaceutical markets, Slovenian drugmaker Krka has so far not achieved the pace of expansion expected. The company's 2010 and Q111 results... 2011-05-16

BMI View: The confirmation that European member states were not using Greece as a reference country for pricing drugs was somewhat expected. However, BMI believes the news should be... 2011-05-13

BMI View: Our projections that Romania's pharmaceutical market will continue to see high-single-digit growth into 2011 have now been confirmed. However, we continue to highlight risks... 2011-05-11

BMI View: Our view that Ukraine's pharmaceutical market will continue to see strong-double-digit growth into 2011 have now been confirmed. Supported by a return to economic growth,... 2011-05-11

BMI View: The value of the Doktor Mom over-the-counter (OTC) brand is determined not by its current sales or product portfolio, but by the acquirer's ability to exploit the intangible... 2011-05-10

BMI View: Despite the prospect of lower prices as a result of amendments to the drug reference pricing system, Bulgaria's pharmaceutical market looks set for high single-figure growth... 2011-05-09

BMI View: The findings of a survey by Turkey's Association of Research-Based Pharmaceutical Companies (AiFD's) have reinforced BMI's own view on the endemic challenges in this market.... 2011-05-06